| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 17080430
[patent_doc_number] => 20210275436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => SEDATIVE LACED TOOTHPASTE
[patent_app_type] => utility
[patent_app_number] => 17/326067
[patent_app_country] => US
[patent_app_date] => 2021-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1752
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17326067
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/326067 | Sedative laced toothpaste | May 19, 2021 | Issued |
Array
(
[id] => 18434433
[patent_doc_number] => 20230181727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => COMPOSITION OF NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/924258
[patent_app_country] => US
[patent_app_date] => 2021-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17505
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17924258
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/924258 | COMPOSITION OF NANOPARTICLES | May 11, 2021 | Pending |
Array
(
[id] => 18510117
[patent_doc_number] => 20230226218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => Red Cell Extracellular Vesicles (RCEVs) Containing Cargoes and Methods of Use and Production Thereof
[patent_app_type] => utility
[patent_app_number] => 17/924284
[patent_app_country] => US
[patent_app_date] => 2021-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26952
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17924284
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/924284 | Red Cell Extracellular Vesicles (RCEVs) Containing Cargoes and Methods of Use and Production Thereof | May 10, 2021 | Pending |
Array
(
[id] => 19367437
[patent_doc_number] => 12059499
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-13
[patent_title] => Liposome loading
[patent_app_type] => utility
[patent_app_number] => 17/313334
[patent_app_country] => US
[patent_app_date] => 2021-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 23395
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17313334
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/313334 | Liposome loading | May 5, 2021 | Issued |
Array
(
[id] => 16990149
[patent_doc_number] => 20210228569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => PARTICLE AND PHARMACEUTICAL COMPOSITION COMPRISING AN INSOLUBLE CAMPTOTHECIN COMPOUND WITH DOUBLE CORESHELL STRUCTURE AND METHOD FOR MANUFACTURING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/233091
[patent_app_country] => US
[patent_app_date] => 2021-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11218
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17233091
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/233091 | PARTICLE AND PHARMACEUTICAL COMPOSITION COMPRISING AN INSOLUBLE CAMPTOTHECIN COMPOUND WITH DOUBLE CORESHELL STRUCTURE AND METHOD FOR MANUFACTURING THE SAME | Apr 15, 2021 | Abandoned |
Array
(
[id] => 17005319
[patent_doc_number] => 20210236480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => PARTICLE AND PHARMACEUTICAL COMPOSITION COMPRISING AN INSOLUBLE CAMPTOTHECIN COMPOUND WITH DOUBLE CORE-SHELL STRUCTURE AND METHOD FOR MANUFACTURING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/233069
[patent_app_country] => US
[patent_app_date] => 2021-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11242
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 267
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17233069
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/233069 | Particle and pharmaceutical composition comprising an insoluble camptothecin compound with double core-shell structure and method for manufacturing the same | Apr 15, 2021 | Issued |
Array
(
[id] => 18716482
[patent_doc_number] => 11793803
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => Particle and pharmaceutical composition comprising an insoluble camptothecin compound with double core-shell structure and method for manufacturing the same
[patent_app_type] => utility
[patent_app_number] => 17/233040
[patent_app_country] => US
[patent_app_date] => 2021-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11247
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 253
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17233040
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/233040 | Particle and pharmaceutical composition comprising an insoluble camptothecin compound with double core-shell structure and method for manufacturing the same | Apr 15, 2021 | Issued |
Array
(
[id] => 17140111
[patent_doc_number] => 20210308122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => PARTICLE AND PHARMACEUTICAL COMPOSITION COMPRISING AN INSOLUBLE CAMPTOTHECIN COMPOUND WITH DOUBLE CORESHELL STRUCTURE AND METHOD FOR MANUFACTURING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/233153
[patent_app_country] => US
[patent_app_date] => 2021-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11232
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17233153
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/233153 | PARTICLE AND PHARMACEUTICAL COMPOSITION COMPRISING AN INSOLUBLE CAMPTOTHECIN COMPOUND WITH DOUBLE CORESHELL STRUCTURE AND METHOD FOR MANUFACTURING THE SAME | Apr 15, 2021 | Abandoned |
Array
(
[id] => 19209580
[patent_doc_number] => 11998616
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-04
[patent_title] => Nanoparticles for crossing the blood brain barrier and methods of treatment using the same
[patent_app_type] => utility
[patent_app_number] => 17/215443
[patent_app_country] => US
[patent_app_date] => 2021-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 29
[patent_no_of_words] => 32407
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17215443
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/215443 | Nanoparticles for crossing the blood brain barrier and methods of treatment using the same | Mar 28, 2021 | Issued |
Array
(
[id] => 17434727
[patent_doc_number] => 11260033
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-01
[patent_title] => Compositions for the delivery of therapeutic agents and methods of use and making thereof
[patent_app_type] => utility
[patent_app_number] => 17/211616
[patent_app_country] => US
[patent_app_date] => 2021-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 27
[patent_no_of_words] => 35767
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17211616
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/211616 | Compositions for the delivery of therapeutic agents and methods of use and making thereof | Mar 23, 2021 | Issued |
Array
(
[id] => 16946528
[patent_doc_number] => 20210205219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => Stabilizing Camptothecin Pharmaceutical Compositions
[patent_app_type] => utility
[patent_app_number] => 17/208042
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34384
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17208042
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/208042 | Stabilizing camptothecin pharmaceutical compositions | Mar 21, 2021 | Issued |
Array
(
[id] => 16946512
[patent_doc_number] => 20210205203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => COSMETIC COMPOSITION COMPRISING PARTICLES CONTAINING HIGH CONTENT OF CERAMIDE AND METHOD FOR PREPARING SAME
[patent_app_type] => utility
[patent_app_number] => 17/206454
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7023
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17206454
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/206454 | COSMETIC COMPOSITION COMPRISING PARTICLES CONTAINING HIGH CONTENT OF CERAMIDE AND METHOD FOR PREPARING SAME | Mar 18, 2021 | Abandoned |
Array
(
[id] => 18642355
[patent_doc_number] => 11766408
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-26
[patent_title] => Compositions and methods for organ specific delivery of nucleic acids
[patent_app_type] => utility
[patent_app_number] => 17/191975
[patent_app_country] => US
[patent_app_date] => 2021-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 57
[patent_no_of_words] => 45766
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 908
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17191975
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/191975 | Compositions and methods for organ specific delivery of nucleic acids | Mar 3, 2021 | Issued |
Array
(
[id] => 16930940
[patent_doc_number] => 20210196829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => NANOPARTICLES WITH ENHANCED MUCOSAL PENETRATION OR DECREASED INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 17/184087
[patent_app_country] => US
[patent_app_date] => 2021-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23803
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17184087
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/184087 | NANOPARTICLES WITH ENHANCED MUCOSAL PENETRATION OR DECREASED INFLAMMATION | Feb 23, 2021 | Abandoned |
Array
(
[id] => 16868351
[patent_doc_number] => 20210161818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => PREPARATION AND STORAGE OF LIPOSOMAL RNA FORMULATIONS SUITABLE FOR THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/170826
[patent_app_country] => US
[patent_app_date] => 2021-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -108
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17170826
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/170826 | Preparation and storage of liposomal RNA formulations suitable for therapy | Feb 7, 2021 | Issued |
Array
(
[id] => 18707447
[patent_doc_number] => 20230330021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => DRUG-LOADED POLYMER VESICLE HAVING ASYMMETRIC MEMBRANE STRUCTURE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN PREPARATION OF DRUGS FOR TREATING ACUTE MYELOID LEUKEMIA
[patent_app_type] => utility
[patent_app_number] => 18/012611
[patent_app_country] => US
[patent_app_date] => 2021-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18012611
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/012611 | DRUG-LOADED POLYMER VESICLE HAVING ASYMMETRIC MEMBRANE STRUCTURE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN PREPARATION OF DRUGS FOR TREATING ACUTE MYELOID LEUKEMIA | Jan 31, 2021 | Abandoned |
Array
(
[id] => 19089791
[patent_doc_number] => 11951211
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-09
[patent_title] => DNA brick-assisted liposome sorting
[patent_app_type] => utility
[patent_app_number] => 17/162008
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 43
[patent_no_of_words] => 18699
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17162008
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/162008 | DNA brick-assisted liposome sorting | Jan 28, 2021 | Issued |
Array
(
[id] => 17748079
[patent_doc_number] => 20220226282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => Natural Product Antidotes against Botulinum Neurotoxins
[patent_app_type] => utility
[patent_app_number] => 17/151233
[patent_app_country] => US
[patent_app_date] => 2021-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4875
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17151233
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/151233 | Natural Product Antidotes against Botulinum Neurotoxins | Jan 17, 2021 | Abandoned |
Array
(
[id] => 18197294
[patent_doc_number] => 20230050813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => NUCLEIC ACID LOADED RED BLOOD CELL EXTRACELLULAR VESICLES
[patent_app_type] => utility
[patent_app_number] => 17/792259
[patent_app_country] => US
[patent_app_date] => 2021-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19242
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17792259
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/792259 | NUCLEIC ACID LOADED RED BLOOD CELL EXTRACELLULAR VESICLES | Jan 11, 2021 | Abandoned |
Array
(
[id] => 17561609
[patent_doc_number] => 20220125758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => PREPARATION METHOD FOR LIPOSOME HAVING ABILITY TO STABLY ENCAPSULATE ACTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 17/133669
[patent_app_country] => US
[patent_app_date] => 2020-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7730
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17133669
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/133669 | Preparation method for liposome having ability to stably encapsulate active ingredient | Dec 23, 2020 | Issued |